View agendas, photos, and videos from past Glaucoma 360 New Horizons Forum events.
2024 New Horizons
Keynote Speaker: Sean Ianchulev, MD, MPH – “The Innovation Journey of an iDoctor”
HIGHLIGHTS:
- The Future of Interventional Glaucoma, with Ike Ahmad, MD, FRSC
- Transforming Glaucoma Care: Addressing Unmet Needs, with Ronald Fellman, MD, Leon Herndon, Jr, MD, Rafael Chan, Jeffrey Goldberg, MD, PhD, Brandy Keys, MPH, and Tonian McDonald
2023 New Horizons
Keynote Speaker: Malik Y. Kahook, MD — “Sustained Drug Delivery for Glaucoma: From Promise to Reality”
HIGHLIGHTS:
- The Future in Vision Restoration and Neuroprotection, with Kimberly Gokoffski, MD, PhD, Jeffrey Goldberg, MD, PhD, and Wiley Chambers, MD
- Optimeyezing Eye Care: How to Improve Data Acquisition, Management and Patient Engagement, with Amanda Bicket, MD, MSE, Sarah Van Tassel, MD, and Malvina Eydelman, MD
2022 New Horizons
Keynote Speaker: Ranya Habash, MD — “The Future of Eye Care: Science Fiction to Science Fact”
HIGHLIGHTS:
- Next Generation Strategies for Vision Restoration, with Jeffrey Goldberg, MD, PhD, Yvonne Ou, MD, Bo Chen, PhD, Anna La Torre, PhD, and Tonia Rex, PhD
- Innovations in the Clinic, with Inder Paul Singh, MD, Ike Ahmed, MD, FRCSC, and Sahar Bedrood, MD, PhD
2021 New Horizons
Keynote Speaker: George A. Cioffi, MD — “What Predictions Came True?”
HIGHLIGHTS:
- Healthcare Delivery, Pandemic and Beyond, with Ruth Williams, MD and Anup K. Khatana, MD
- Global Innovations, with Malik Kahook, MD, Suman Thapa, MD, PhD, Sahar Bedrood, MD, PhD, Pearse Keane, MD, Kaweh Mansouri, MD, PhD, and Nathan M. Radcliffe, MD
2020 New Horizons
Keynote Speaker: David W. Parke II, MD — “When Cost and Innovation Collide in Ophthalmology”
HIGHLIGHTS:
- Show Me the Money: Getting to Go in Early Stage Glaucoma Financing, with Emmett Cunningham, Jr., MD, PhD, MPH and Christy Shaffer, PhD
- Innovation 101: How to Translate an Idea into Breakthrough Therapies, with Adrienne Graves, PhD and Malik Kahook, MD
2019 New Horizons
Keynote Speaker: Janey L. Wiggs, MD, PhD — “Glaucoma Genetics: Working Toward a Cure”
HIGHLIGHTS:
- New Horizons in Vision Restoration: Innovations in Regenerative Ophthalmology, with David Calkins, PhD, Joel Schuman, MD, FACS, Adriana di Polo, PhD, Yiqin Du, MD, PhD, Karl Kador, PhD, Kenneth Mandell, MD, PhD, and Jeffrey Goldberg, MD, PhD
- Telemedicine: Promising Future for Glaucoma Management, with Lama Al-Aswad, MD, MPH and Felipe Medeiros, MD, PhD
2018 New Horizons
Keynote Speaker: Ike K. Ahmed, MD, FRCSC — “Interventional Glaucoma: The Why, The Who, and The How”
HIGHLIGHTS:
- New Horizons in Virtual Reality, with Andrew Huberman, PhD and Felipe Medeiros, MD, PhD
- New Horizons in Glaucoma Devices, with E. Randy Craven, MD and Eydie G. Miller-Ellis, MD
2017 New Horizons
Keynote Speaker: Joel S. Schuman, MD, FACS — “Optical Coherence Tomography — Past, Present, and Future”
HIGHLIGHTS:
- Biomarkers and Drug Discovery: Integrating Therapeutic and Diagnostic Trials, with David Calkins, PhD and Jeffrey Goldberg, MD, PhD
- New Horizons in Glaucoma Drug Delivery, with L. Jay Katz, MD and Cheryl Rowe-Rendleman, PhD
2016 New Horizons
Keynote Speaker: Richard A. Lewis, MD — “Bullish on Glaucoma, A 30-Year Perspective on Patient Care, Clinical Research, and Industry”
HIGHLIGHTS:
- Funding Innovation: Securing Capital to Finance Your Start-up, with Emmett Cunningham, Jr., MD, PhD, MPH
- New Horizons in Glaucoma Treatment: From Vision Restoration to Optic Nerve Regeneration, with Anthony Adamis, MD, Jay Katz, MD, Larry Benowitz, PhD, Kapil Bharti, PhD, and Bernhard A. Sabel, PhD
2015 New Horizons
Keynote Speaker: Paul P. Lee, MD, JD — “Opportunities and Challenges for Innovation in Glaucoma”
HIGHLIGHTS:
- New Horizons in IOP Monitoring, Diagnostics, and Digital Health, with Robert N. Weinreb, MD and Rohit Varma, MD, MPH
- Catalyst for a Cure Biomarkers Initiative: “Early Neuronal Changes: Markers for Glaucoma” – with Andrew D. Huberman, PhD and Thomas M. Brunner
2014 New Horizons
Keynote Speaker: Robert N. Weinreb, MD — “Personalizing Intraocular Pressure to Manage Glaucoma”
HIGHLIGHTS:
- The Challenges of Reimbursement, with Ruth Williams, MD and William L. Rich, III, MD, FACS
- New Horizons in Glaucoma Pharmaceuticals, with Stuart B. Abelson, MBA and Joel Schuman, MD, FACS
2013 New Horizons
Keynote Speaker: Louis Cantor, MD, “State of Glaucoma Therapy 2013: Is 13 our lucky number?”
HIGHLIGHTS:
- Advancing New Horizons: Focusing on Collaboration and Public Private Partnerships, with M. Roy Wilson, MD, MS, Anne L. Coleman, MD, PhD, Frank L. Douglas, PhD, MD, and Debra R. Lappin, JD
- New Horizons in Glaucoma Drug Delivery, with Eugene de Juan, Jr., MD and Eliot Lazar, MD